MedPath

Study conducted in a tertiary care hospital for a period of one year, aims to observe the number of new cases and better understand the treatment of infections caused by bacteria belonging to Enterobacteriaceae species that are resistant to an antibiotic class called Carbapenems.

Not Applicable
Conditions
Health Condition 1: J150- Pneumonia due to Klebsiella pneumoniaeHealth Condition 2: A415- Sepsis due to other Gram-negativeorganismsHealth Condition 3: N390- Urinary tract infection, site notspecified
Registration Number
CTRI/2023/04/051953
Lead Sponsor
Gaurav Girish
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ADULT PATIENT WITH CRE INFECTION CAUSED BY E.COLI OR K.PNEUMONIAE

Exclusion Criteria

PATIENTS WHO DO NOT PROVIDE CONSENT

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
INCIDENCE OF CRE INFECTIONS and COMPARISION OF MANAGEMENT GUIDELINES FOLLOWED IN TERTIARY CARE HOSPITAL WITH ICMR GUIDELINESTimepoint: April 2023 to March 2024
Secondary Outcome Measures
NameTimeMethod
COMPARISION OF MANAGEMENT WITH ICMR GUIDELINESTimepoint: MAY 2023 TO MAY 2024
© Copyright 2025. All Rights Reserved by MedPath